Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy
ContextObesity has been reported as a potential risk factor for the aggressiveness of papillary thyroid cancer (PTC), but the data gathered so far are conflicting.ObjectiveThe aim of our study was to evaluate the relationship between body mass index (BMI) and aggressiveness of PTC at the diagnosis a...
Main Authors: | Jingjia Cao, Xiaolu Zhu, Yaru Sun, Xiao Li, Canhua Yun, Wei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.870530/full |
Similar Items
-
Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
by: Hengqiang Zhao, et al.
Published: (2022-08-01) -
Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
by: Jonghwa Ahn, et al.
Published: (2020-03-01) -
Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
by: Lina Liu, et al.
Published: (2022-05-01) -
Analysis of tumor recurrence factors of the patients with intermediate risk papillary thyroid carcinoma after radioactive iodine treatment
by: TANG Linglin, LI Li, LAI Yi, LIU Jianjun, ZHOU Xiang
Published: (2023-11-01) -
Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid
by: Jain Ankit, et al.
Published: (2009-06-01)